Expand DARE Menu
DARE MENU

DARE Latest Press Releases

-- December 10, 2025 --

DARE to PLAY Sildenafil Cream Now Available for Pre-Order by Prescription: First Evidence-Based Topical Arousal Cream for Women Begins Commercial Rollout in Select States via 503B Outsourcing Facility Globe Newswire 8:00 AM

-- December 1, 2025 --

Dar Bioscience Announces Return of Rights to Ovaprene; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization Globe Newswire 8:00 AM

-- November 24, 2025 --

Dar Bioscience Receives $3.6 Million in Additional Grant Funding Globe Newswire 8:00 AM

-- November 13, 2025 --

Dar Bioscience Reports Third Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 4:01 PM

-- November 11, 2025 --

Dar Bioscience Highlights Commercial Launch Readiness for DARE to PLAY Sildenafil Cream; November 17th Webinar to Feature Leading Clinicians Discussing Clinical Data and Potential Impact in Women's Sexual Health Globe Newswire 8:00 AM

-- November 6, 2025 --

Dar Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025 Globe Newswire 8:00 AM

-- November 3, 2025 --

Dar Bioscience to Receive up to $300,000 to Conduct Global Contraceptive Innovation Capabilities Landscape Assessment Globe Newswire 8:00 AM

-- October 6, 2025 --

Dar Bioscience Receives $4 Million Non-Dilutive Grant Installment; Total of $41.8M Received to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders Globe Newswire 8:00 AM

-- September 24, 2025 --

Dar Bioscience to Receive up to $499,000 to Support Preeclampsia Research Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes